Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
KC1036
i
Other names:
KC1036
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Konruns Pharma
Drug class:
FLT3 inhibitor, VEGFR-2 inhibitor, Tyrosine kinase inhibitor, AXL inhibitor
Related drugs:
‹
quizartinib (40)
ARO-002 (25)
PHI-101 (12)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
CA-4948 (6)
CG-806 (6)
AST-487 (5)
CB-659 (4)
FF-10101 (3)
pacritinib (3)
CEP-701 (3)
BGS-2456 (2)
HPB-092 (2)
fedratinib (2)
JRF104 (2)
MEN1703 (2)
Max-40279 (2)
UNC2025 (2)
HEC73543 (2)
ABT-869 (2)
HM43239 (2)
TG02 (2)
AG-1296 (1)
AIU2008 (1)
CDDD11-8 (1)
D-65476 (1)
E6201 (1)
EC-70124 (1)
KF-1601 (1)
KRC-108 (1)
PLD-102 (1)
STI-8591 (1)
XY0206 (1)
AM-5992 (0)
BMF-500 (0)
CCT137690 (0)
CLN-049 (0)
CTS2016 (0)
D-64406 (0)
EP0042 (0)
FLX925 (0)
FN-1501 (0)
4G8-SDIEM (0)
HYML-122 (0)
KW-2449 (0)
LT-171-861 (0)
MG-D-1509 (0)
MRX2843 (0)
NMS-088 (0)
R1530 (0)
RF-1302 (0)
SU 14813 (0)
SKI-G-801 (0)
flonoltinib (0)
SKLB-1028 (0)
rivoceranib (82)
ramucirumab (59)
RAF265 (7)
tivozanib (3)
GSK1363089 (2)
GB-103 (2)
OSI-930 (1)
BMS-582664 (1)
E7050 (1)
pegdinetanib (0)
BMS690514 (0)
BTG-002814 (0)
C019199 (0)
JI-101 (0)
JY025 (0)
MSB0254 (0)
NCE 401 (0)
VEGFR2-169 (0)
VXM01 (0)
DCC-2701 (0)
Gensci048 (0)
gentuximab (0)
TTAC-0001 (0)
TSU-68 (0)
AK109 (0)
SYHA1817 (0)
ASA404 (0)
PD173074 (10)
BBT-176 (5)
E 3810 (4)
befotertinib (3)
CLN-081 (2)
vorolanib (1)
rilertinib (1)
quercetin (0)
Tyrosine Kinase inhibitors (0)
SU5416 (0)
XL092 (0)
BGB324 (26)
TP-0903 (13)
AVB-500 (4)
MGCD265 (4)
ONO-7475 (3)
AB-329 (2)
BPI-9016M (2)
AX-0085 (0)
INCB81776 (0)
PF-07265807 (0)
RXDX-106 (0)
S-49076 (0)
SLC-391 (0)
Q702 (0)
BGB149 (0)
quizartinib (40)
ARO-002 (25)
PHI-101 (12)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
CA-4948 (6)
CG-806 (6)
AST-487 (5)
CB-659 (4)
FF-10101 (3)
pacritinib (3)
CEP-701 (3)
BGS-2456 (2)
HPB-092 (2)
fedratinib (2)
JRF104 (2)
MEN1703 (2)
Max-40279 (2)
UNC2025 (2)
HEC73543 (2)
ABT-869 (2)
HM43239 (2)
TG02 (2)
AG-1296 (1)
AIU2008 (1)
CDDD11-8 (1)
D-65476 (1)
E6201 (1)
EC-70124 (1)
KF-1601 (1)
KRC-108 (1)
PLD-102 (1)
STI-8591 (1)
XY0206 (1)
AM-5992 (0)
BMF-500 (0)
CCT137690 (0)
CLN-049 (0)
CTS2016 (0)
D-64406 (0)
EP0042 (0)
FLX925 (0)
FN-1501 (0)
4G8-SDIEM (0)
HYML-122 (0)
KW-2449 (0)
LT-171-861 (0)
MG-D-1509 (0)
MRX2843 (0)
NMS-088 (0)
R1530 (0)
RF-1302 (0)
SU 14813 (0)
SKI-G-801 (0)
flonoltinib (0)
SKLB-1028 (0)
rivoceranib (82)
ramucirumab (59)
RAF265 (7)
tivozanib (3)
GSK1363089 (2)
GB-103 (2)
OSI-930 (1)
BMS-582664 (1)
E7050 (1)
pegdinetanib (0)
BMS690514 (0)
BTG-002814 (0)
C019199 (0)
JI-101 (0)
JY025 (0)
MSB0254 (0)
NCE 401 (0)
VEGFR2-169 (0)
VXM01 (0)
DCC-2701 (0)
Gensci048 (0)
gentuximab (0)
TTAC-0001 (0)
TSU-68 (0)
AK109 (0)
SYHA1817 (0)
ASA404 (0)
PD173074 (10)
BBT-176 (5)
E 3810 (4)
befotertinib (3)
CLN-081 (2)
vorolanib (1)
rilertinib (1)
quercetin (0)
Tyrosine Kinase inhibitors (0)
SU5416 (0)
XL092 (0)
BGB324 (26)
TP-0903 (13)
AVB-500 (4)
MGCD265 (4)
ONO-7475 (3)
AB-329 (2)
BPI-9016M (2)
AX-0085 (0)
INCB81776 (0)
PF-07265807 (0)
RXDX-106 (0)
S-49076 (0)
SLC-391 (0)
Q702 (0)
BGB149 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MET exon 14 mutation
Lung Adenocarcinoma
MET exon 14 mutation
Lung Adenocarcinoma
KC1036
Sensitive: D – Preclinical
KC1036
Sensitive
:
D
KC1036
Sensitive: D – Preclinical
KC1036
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login